āĻšā§āĻŽBOI âĸ EPA
add
Boiron SA
ā§Šā§Ļ.ā§Ēā§ĻâŦ
⧍⧍ āĻāĻžāύā§, ā§§ā§§:ā§Ģā§:⧍⧧ AM GMT +ā§§ · EUR · EPA · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§Šā§Ļ.ā§Ēā§ĻâŦ
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
⧍⧝.ā§ā§ĻâŦ - ā§Šā§Ļ.ā§Ēā§ĻâŦ
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
⧍ā§Ļ.ā§Žā§ĢâŦ - ā§Šā§¨.⧍ā§ĢâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§Ģā§Š.ā§Šā§Ē āĻā§ EUR
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§§.ā§§ā§ŽÂ āĻšāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
⧍ā§.⧍ā§Ģ
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
EPA
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
| (EUR) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ⧧⧍.ā§¨ā§ŽÂ āĻā§ | ā§.ā§Ģā§Ž% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§.⧝ā§Ŧ āĻā§ | ā§Ļ.ā§Ēā§Ž% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Ģā§Ŧ.ā§Žā§¨Â āϞāĻž | ⧍ā§Ēā§§.ā§Ļā§Ŧ% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ā§Ē.ā§Ŧā§Š | ⧍⧧ā§.⧧⧍% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | â | â |
EBITDA | ā§§.ā§Ŧā§Ģ āĻā§ | ā§ā§¯.ā§Ļ⧝% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ⧍ā§Ģ.ā§Šā§% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (EUR) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§Ŧ.⧍ā§Ē āĻā§ | ā§§ā§.ā§§ā§Ļ% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§Ģā§Ŧ.ā§§ā§Ŧ āĻā§ | ā§Ļ.ā§ā§§% |
āĻŽā§āĻ āĻĻāĻžā§ | ⧧⧝.⧍ā§Ģ āĻā§ | ā§Ē.⧍⧧% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Šā§Ŧ.ā§¯ā§§Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§.ā§ā§Ē āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§§.ā§Ēā§Š | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§Ē.ā§Žā§¯% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§.ā§Ļ⧝% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
| (EUR) | āĻā§āύ ⧍ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§Ģā§Ŧ.ā§Žā§¨Â āϞāĻž | ⧍ā§Ēā§§.ā§Ļā§Ŧ% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§§.ā§Šā§Ģ āĻā§ | ā§¯ā§Ž.⧝⧝% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Ēā§Ļ.ā§Ģā§¨Â āϞāĻž | ⧍ā§Ļ.ā§Ēā§§% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§§.ā§§ā§¨Â āĻā§ | ā§§ā§Ģ.⧍ā§Ŧ% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | -ā§§ā§§.ā§Ģā§§Â āϞāĻž | ā§Žā§¯.ā§Žā§Ŧ% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ⧝ā§Ŧ.⧍ā§Â āϞāĻž | ā§§ā§§ā§Ž.ā§Ŧā§Š% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of âŦ 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§ āĻā§āύ, ā§§ā§¯ā§Šā§¨
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
⧍,ā§ā§Šā§Ŧ